HELEN HESLOP to Multicenter Studies as Topic
This is a "connection" page, showing publications HELEN HESLOP has written about Multicenter Studies as Topic.
Connection Strength
0.171
-
Harmonizing Immune Effector Toxicity Reporting. Biol Blood Marrow Transplant. 2019 04; 25(4):e121-e122.
Score: 0.136
-
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant. 2011 Feb; 17(2):192-6.
Score: 0.020
-
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease. Blood. 2007 Mar 15; 109(6):2657-62.
Score: 0.015